NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Talks Bold Strategy to Treat GBM in BioMedWire Podcast
CNS Pharmaceuticals (NASDAQ: CNSP) was featured in a BioMedWire Podcast discussing its sharpened focus on glioblastoma multiforme (“GBM”), one of the deadliest and least treatable forms of cancer. In the interview, CEO John Climaco said of GBM, “Patients have very little hope. Our mission is to change that completely, and we think we have the drugs to do it.” An article discussing this reads, “The company’s therapeutic strategy centers on overcoming the blood-brain barrier (‘BBB’), a critical biological defense that restricts most drugs from reaching brain tumors. ‘The problem for patients and clinicians in the space is that the cancers take…







